According to ImmunoGen 's latest financial reports and stock price the company's current number of shares outstanding is 273,341,000. At the end of 2023 the company had 273,341,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.27 B | 7.44% |
2022 | 0.25 B | 17.87% |
2021 | 0.21 B | 14.39% |
2020 | 0.18 B | 26.79% |
2019 | 0.14 B | 1.03% |
2018 | 0.14 B | 18.22% |
2017 | 0.12 B | 43.03% |
2016 | 87.1 M | 0.15% |
2015 | 86.97 M | 0.35% |
2014 | 86.66 M | -0.7% |
2013 | 87.27 M | 3.72% |
2012 | 84.14 M | 9.96% |
2011 | 76.52 M | 12.59% |
2010 | 67.96 M | 18.91% |
2009 | 57.15 M | 12.46% |
2008 | 50.82 M | 19.02% |
2007 | 42.7 M | 2.72% |
2006 | 41.57 M | 1.2% |
2005 | 41.07 M | 0.68% |
2004 | 40.8 M | 0.5% |
2003 | 40.59 M | -5.09% |
2002 | 42.77 M | 7.66% |
2001 | 39.73 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 780.66% | ๐บ๐ธ USA |
Novartis NVS | 2,044,000,000 | 647.78% | ๐จ๐ญ Switzerland |
Pfizer PFE | 5,647,000,000 | 1,965.92% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 247.32% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 95.73% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 817.24% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | 2,023,000,000 | 640.10% | ๐บ๐ธ USA |
Seagen
SGEN | 188,135,000 | -31.17% | ๐บ๐ธ USA |